KMT2A and metastatic neoplasm: One injection of MLL-EVs significantly increased macrophage infiltration (CD68) to the normal prostate tissue in vivo compared to G-EVs and PBS injected controls, suggesting that EVs from metastatic tumors could increase macrophage infiltration to the normal tissue surrounding the tumor.